Travere Therapeutics, Inc. TVTX Payment Of Guaranteed Minimum Royalty
Payment Of Guaranteed Minimum Royalty at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept tvtx:PaymentOfGuaranteedMinimumRoyalty.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s payment of guaranteed minimum royalty.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s payment of guaranteed minimum royalty?
- Travere Therapeutics, Inc. (TVTX) reported payment of guaranteed minimum royalty of $525K in Q1 2026.
- How has Travere Therapeutics, Inc.'s payment of guaranteed minimum royalty changed year-over-year?
- Travere Therapeutics, Inc.'s payment of guaranteed minimum royalty decreased by 0.0% year-over-year, from $525K to $525K.
- What is the long-term trend for Travere Therapeutics, Inc.'s payment of guaranteed minimum royalty?
- Over 4 years (2021 to 2025), Travere Therapeutics, Inc.'s payment of guaranteed minimum royalty has grown at a 0.0% compound annual growth rate (CAGR), from $2.1M to $2.1M.
- What does payment of guaranteed minimum royalty mean?
- Represents mandatory cash payments made to licensors or partners regardless of the actual sales performance of a licensed product. This metric highlights fixed contractual obligations that impact cash flow stability and long-term profitability.